| IPO Company Profile © ipodata.com |
| Message Board | Quote | Chart | News | SEC Filings | Peer IPO Companies |
| Odyssey HealthCare, Inc. |
| 717 N. Harwood, Suite 1500, Dallas, TX 75201 * (214) 922-9711 |
| Business Description | The company is a leading provider of hospice services in the United States. As a hospice care provider, our goal is to improve the quality of life of terminally ill patients and their families. Hospice services focus on palliative care for patients with life-limiting illnesses, which is care directed at managing pain and other discomforting symptoms and addressing the psychosocial and spiritual needs of patients and their families. |
| Offering Information Company has | |||
| Trading As | ODSY (NASNTL) | Industry | Service (SIC 8051) |
| Type of Stock Offered | Common Shares | Filing Date | 12/8/2000 |
| Domestic Shares Offered | 3,600,000 | Offer Date | 10/30/2001 |
| Foreign Shares Offered | 0 | Filing Range | $13.00 - $15.00 |
| Company Shares | 3,600,000 | Offer Price | $15.00 |
| Selling Shrhldrs Shares | 0 | Gross Spread | $0.630 |
| Gross Proceeds | $54,000,000 | Selling | $0.210 |
| Expenses | - - | Reallowance | $0.100 |
| Post-IPO Shares | 13,698,182 | Employees | - - |
| Primary Underwriting Group | ||
| Underwriter Name | Participation | Underwriter Phone |
| Merrill Lynch & Co. | Lead Manager | (212) 449-4600 |
| CIBC World Markets | Co-manager | (212) 667-7400 |
| SG Cowen | Co-manager | (212) 495-6000 |
| Income Statement and Cash Flow Summary | |||||||
| Prior Audited Income |
Latest Unaudited Income | ||||||
| Full Year Audited Figures | 9 Months Ending | ||||||
| Figures in U.S. millions except per share data | 12/31/1997 | 12/31/1998 | 12/31/1999 | 9/30/1999 | 9/30/2000 | ||
| Revenues | - | - | 6.901 | 27.239 | 46.460 | 32.925 | 58.853 |
| Income from Oper. | - | - | -4.442 | -5.602 | -0.026 | -0.781 | 4.588 |
| Net Income | - | - | -4.143 | -6.523 | -2.200 | -2.299 | 2.161 |
| E.P.S | - | - | -1.370 | -2.060 | -0.910 | -0.850 | 0.310 |
| Revenue Growth (%) | - | - | 294.69 | 70.567 | 78.75 | ||
| Net Income Growth (%) | - | - | - | - | - | ||
| Oper. Profit Margin (%) | - | - | - | - | - | 7.80 | - |
| Net Profit Margin (%) | - | - | - | - | - | 3.67 | - |
| Cash Flow - Oper. | -1.59 | -0.30 | 3.11 | ||||
| Cash Flow - Inv. | -5.34 | -1.36 | -0.40 | ||||
| Cash Flow - Fin. | 6.70 | 1.15 | -2.93 | ||||
| Balance Sheet Summary and Financial Ratios | |||||
| Balance sheet as of: 9/30/2000 | Financial Ratios | ||||
| Total Assets | 34.94 | Current Assets | 17.54 | Current Ratio | 0.97 |
| Total Liab. | 50.09 | Current Liab. | 18.07 | Debt Ratio | 143.35% |
| Total Equity | -15.15 | Working Cap. | -0.53 | Debt to Equity Ratio | - |
| Cash | 0.15 | Return on Assets | 6.18% | ||
| Use Of Proceeds |
The proceeds from the proposed offering will be used to repay all outstanding indebtedness under a credit agreement, to repay 12% senior subordinated notes, to finance potential acquisitions of hospices and the development of new hospice locations and for general corporate purposes. |
| Legal Counsel Registrar Auditor | |
| Issuer's Law Firm | Vinson & Elkins |
| Bank's Law Firm | Debevoise & Plimpton |
| Registrar/Transfer Agent | U. S. Stock Transfer Corporation |
| Auditor | Ernst & Young |
| Send us feedback if you would like to request that we hyperlink a firm on this page | |
| Principal Shareholders | ||
| Name of Shareholder | % Owned Before | % Owned After |
| Entities affiliated with Three Arch Partners | 20.31 | |
| Entities affiliated with Weiss Peck & Greer | 20.06 | |
| Entities affiliated with Oak Investment Partners | 19.77 | |
| Entities affiliated with Capital Resource Partners | 14.20 | |
| Entities affiliated with Highland Capital Partners | 9.02 | |
| Note: represents ownership of 5% or more prior to the offering. | ||